U.S. Pharmaceuticals & Biotech Stocks - Top Gainers Today

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Jan 06, 2026

Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.

721 companies

Company	Last Price	1D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
LLY Eli Lilly	US$1,064.04	2.2%	37.6%	US$932.5b	US$1,098.04	PE51.7x	E20.1%	0.7%
ABBV AbbVie	US$223.93	1.7%	24.7%	US$389.1b	US$244.68	PE168.6x	E25.4%	3.1%
AMGN Amgen	US$330.17	2.9%	26.0%	US$172.7b	US$327.74	PE25.4x	E6.5%	3.1%
VRTX Vertex Pharmaceuticals	US$468.38	4.4%	14.7%	US$113.9b	US$494.16	PE32.3x	E13.1%	n/a
GILD Gilead Sciences	US$121.36	2.6%	33.9%	US$146.8b	US$132.57	PE18.6x	E7.1%	2.6%
TMO Thermo Fisher Scientific	US$620.72	1.6%	13.8%	US$229.6b	US$641.57	PE35.5x	E10.3%	0.3%
MRK Merck	US$108.87	1.3%	7.8%	US$266.7b	US$110.04	PE14.2x	E6.5%	3.1%
RGC Regencell Bioscience Holdings	US$33.03	22.2%	26,476.2%	US$13.4b	n/a	PB3360.5x	n/a	n/a
BMY Bristol-Myers Squibb	US$54.42	2.6%	-4.8%	US$108.0b	US$55.43	PE18.3x	E1.0%	4.6%
ALMS Alumis	US$16.23	95.3%	111.1%	US$1.7b	US$27.71	PS76.6x	E8.0%	n/a
NTRA Natera	US$248.74	4.8%	46.0%	US$32.8b	US$251.26	PS16.3x	E52.3%	n/a
PFE Pfizer	US$25.43	1.0%	-6.3%	US$143.1b	US$28.62	PE14.8x	E-0.1%	6.8%
REGN Regeneron Pharmaceuticals	US$776.54	1.7%	6.3%	US$78.3b	US$797.27	PE17.4x	E8.5%	0.5%
MRNA Moderna	US$35.66	10.8%	-25.0%	US$12.6b	US$36.90	PS6.2x	E40.5%	n/a
A Agilent Technologies	US$147.60	3.3%	7.4%	US$40.5b	US$168.59	PE32.1x	E9.7%	0.7%
TEVA Teva Pharmaceutical Industries	US$32.11	3.6%	48.7%	US$35.6b	US$34.86	PE51.7x	E11.5%	0%
BIIB Biogen	US$182.61	4.6%	19.2%	US$25.6b	US$182.83	PE16.7x	E6.3%	n/a
JNJ Johnson & Johnson	US$204.79	0.2%	40.0%	US$492.2b	US$211.38	PE19.6x	E2.0%	2.5%
ALNY Alnylam Pharmaceuticals	US$406.40	2.2%	72.2%	US$52.6b	US$490.50	PE1232.4x	E40.8%	n/a
IQV IQVIA Holdings	US$240.53	2.5%	18.7%	US$40.0b	US$253.95	PE31.9x	E13.5%	n/a
INCY Incyte	US$106.66	4.8%	45.7%	US$20.0b	US$100.24	PE17.6x	E-5.4%	n/a
ARWR Arrowhead Pharmaceuticals	US$70.81	10.8%	260.0%	US$8.7b	US$67.50	PS11.6x	E16.7%	n/a
SMMT Summit Therapeutics	US$18.66	7.0%	2.8%	US$13.4b	US$32.61	PB74.8x	E57.4%	n/a
ILMN Illumina	US$147.11	4.1%	5.3%	US$22.5b	US$129.06	PE32x	E9.5%	n/a

Page 1 of 31